Forth Therapeutics
ItalyEntry
2023
Hold
3yr
Status
Active
Who owns Forth Therapeutics?
Forth Therapeutics is an Italian Healthcare / Biotech company, currently owned by Old College Capital since 2025 and Sofinnova Partners.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Biovelocita I · 2022 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
Sofinnova PartnersActive
2023 · present(3yr) · Sofinnova Biovelocita I · 2022 · Life Sciences VC
Old College CapitalActive
2025 · present(1yr) · Old College Capital LP · 2011 · Evergreen
More from Sofinnova Biovelocita I
Other portfolio companies in the same fund.
More Sofinnova Partners portfolio companies
From the same investor, across funds.
France
United Kingdom
United States
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Forth Therapeutics?
Forth Therapeutics is currently owned by Old College Capital and Sofinnova Partners, through Sofinnova Biovelocita I, since 2025.
When did Old College Capital and 1 other acquire Forth Therapeutics?
Old College Capital and 1 other acquired Forth Therapeutics in 2025.
Who has owned Forth Therapeutics over time?
Forth Therapeutics has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Biovelocita I · since 2023; Old College Capital · via Old College Capital LP · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue